| Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma S Lyford-Pike, S Peng, GD Young, JM Taube, WH Westra, B Akpeng, ... Cancer research 73 (6), 1733-1741, 2013 | 841 | 2013 |
| Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability J Zhou, WJ Liu, SW Peng, XY Sun, I Frazer Journal of virology 73 (6), 4972-4982, 1999 | 357 | 1999 |
| Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype CL Trimble, S Piantadosi, P Gravitt, B Ronnett, E Pizer, A Elko, B Wilgus, ... Clinical cancer research 11 (13), 4717-4723, 2005 | 294 | 2005 |
| Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus TW Kim, JH Lee, CF Hung, S Peng, R Roden, MC Wang, R Viscidi, ... Journal of virology 78 (9), 4638-4645, 2004 | 239 | 2004 |
| A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3 CL Trimble, S Peng, F Kos, P Gravitt, R Viscidi, E Sugar, D Pardoll, TC Wu Clinical Cancer Research 15 (1), 361-367, 2009 | 227 | 2009 |
| Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway S Peng, IH Frazer, GJ Fernando, J Zhou Virology 240 (1), 147-157, 1998 | 171 | 1998 |
| Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6 S Peng, H Ji, C Trimble, L He, YC Tsai, J Yeatermeyer, DAK Boyd, ... Journal of virology 78 (16), 8468-8476, 2004 | 168 | 2004 |
| A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer RK Anchoori, B Karanam, S Peng, JW Wang, R Jiang, T Tanno, ... Cancer cell 24 (6), 791-805, 2013 | 166 | 2013 |
| Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery SR Best, S Peng, CM Juang, CF Hung, D Hannaman, JR Saunders, ... Vaccine 27 (40), 5450-5459, 2009 | 161 | 2009 |
| Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment Z Lin, M Bazzaro, MC Wang, KC Chan, S Peng, RBS Roden Clinical Cancer Research 15 (2), 570-577, 2009 | 137 | 2009 |
| Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope CH Huang, S Peng, L He, YC Tsai, DAK Boyd, TH Hansen, TC Wu, ... Gene therapy 12 (15), 1180-1186, 2005 | 119 | 2005 |
| Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion KY Lin, D Lu, CF Hung, S Peng, L Huang, C Jie, F Murillo, J Rowley, ... Cancer research 67 (4), 1832-1841, 2007 | 105 | 2007 |
| Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life S Peng, TW Kim, JH Lee, MU Yang, L He, CF Hung, TC Wu Human gene therapy 16 (5), 584-593, 2005 | 94 | 2005 |
| Moderate reduction of γ-secretase attenuates amyloid burden and limits mechanism-based liabilities T Li, H Wen, C Brayton, FM Laird, G Ma, S Peng, L Placanica, TC Wu, ... Journal of Neuroscience 27 (40), 10849-10859, 2007 | 92 | 2007 |
| HLA-DQB1* 02–restricted HPV-16 E7 peptide–specific CD4+ T-cell immune responses correlate with regression of HPV-16–associated high-grade squamous intraepithelial lesions S Peng, C Trimble, L Wu, D Pardoll, R Roden, CF Hung, TC Wu Clinical cancer research 13 (8), 2479-2487, 2007 | 90 | 2007 |
| Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell–Mediated Tumor Control in the … YY Sun, S Peng, L Han, J Qiu, L Song, Y Tsai, B Yang, RBS Roden, ... Clinical Cancer Research 22 (3), 657-669, 2016 | 81 | 2016 |
| A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects S Peng, TT Tomson, C Trimble, L He, CF Hung, TC Wu Gene therapy 13 (3), 257-265, 2006 | 81 | 2006 |
| Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine S Peng, S Lyford-Pike, B Akpeng, A Wu, CF Hung, D Hannaman, ... Cancer immunology, immunotherapy 62, 171-182, 2013 | 77 | 2013 |
| Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity B Karanam, R Gambhira, S Peng, S Jagu, DJ Kim, GW Ketner, PL Stern, ... Vaccine 27 (7), 1040-1049, 2009 | 75 | 2009 |
| Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein YM Qi, SW Peng, K Hengst, M Evander, DS Park, J Zhou, IH Frazer Virology 216 (1), 35-45, 1996 | 71 | 1996 |
